Cargando…
Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies
Pulmonary hypertension (PH) due to chronic respiratory disease and/or hypoxia is classified as World Health Organization (WHO) Group III pulmonary hypertension. The patients most commonly encountered in clinical practice with group III PH include those with chronic obstructive lung disease (COPD), d...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039478/ https://www.ncbi.nlm.nih.gov/pubmed/27571110 http://dx.doi.org/10.3390/jcm5090075 |
_version_ | 1782456064228196352 |
---|---|
author | Fein, Daniel G. Zaidi, Ali N. Sulica, Roxana |
author_facet | Fein, Daniel G. Zaidi, Ali N. Sulica, Roxana |
author_sort | Fein, Daniel G. |
collection | PubMed |
description | Pulmonary hypertension (PH) due to chronic respiratory disease and/or hypoxia is classified as World Health Organization (WHO) Group III pulmonary hypertension. The patients most commonly encountered in clinical practice with group III PH include those with chronic obstructive lung disease (COPD), diffuse parenchymal lung disease, and sleep-disordered breathing. The purpose of this review is to outline the variable clinical significance of pulmonary hypertension in the most common pulmonary disease states and how a clinician may approach the management of these patients. |
format | Online Article Text |
id | pubmed-5039478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-50394782016-10-04 Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies Fein, Daniel G. Zaidi, Ali N. Sulica, Roxana J Clin Med Review Pulmonary hypertension (PH) due to chronic respiratory disease and/or hypoxia is classified as World Health Organization (WHO) Group III pulmonary hypertension. The patients most commonly encountered in clinical practice with group III PH include those with chronic obstructive lung disease (COPD), diffuse parenchymal lung disease, and sleep-disordered breathing. The purpose of this review is to outline the variable clinical significance of pulmonary hypertension in the most common pulmonary disease states and how a clinician may approach the management of these patients. MDPI 2016-08-26 /pmc/articles/PMC5039478/ /pubmed/27571110 http://dx.doi.org/10.3390/jcm5090075 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Fein, Daniel G. Zaidi, Ali N. Sulica, Roxana Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies |
title | Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies |
title_full | Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies |
title_fullStr | Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies |
title_full_unstemmed | Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies |
title_short | Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies |
title_sort | pulmonary hypertension due to common respiratory conditions: classification, evaluation and management strategies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039478/ https://www.ncbi.nlm.nih.gov/pubmed/27571110 http://dx.doi.org/10.3390/jcm5090075 |
work_keys_str_mv | AT feindanielg pulmonaryhypertensionduetocommonrespiratoryconditionsclassificationevaluationandmanagementstrategies AT zaidialin pulmonaryhypertensionduetocommonrespiratoryconditionsclassificationevaluationandmanagementstrategies AT sulicaroxana pulmonaryhypertensionduetocommonrespiratoryconditionsclassificationevaluationandmanagementstrategies |